POLYMORPHISMS AS PREDICTORS OF TREATMENT RESPONSE AND OVERALL SURVIVAL OF METASTATIC COLORECTAL CANCER
作者： Sivolapenko Grigorios , Papachristos Apostolos
DOI:
关键词:
摘要: The present disclosure relates to methods for determining whether a subject with cancer, in particular metastatic colorectal is likely respond treatment and/or predicting overall survival bevacizumab and fluoropyrimidine-based chemotherapy. also of selecting subject's cancer compounds use the cancer. kits that can be utilised these methods.
lens.org 参考文章(5)
A K Koutras, A G Antonacopoulou, A G Eleftheraki, F-I Dimitrakopoulos, A Koumarianou, I Varthalitis, F Fostira, J Sgouros, E Briasoulis, E Bournakis, D Bafaloukos, I Bompolaki, E Galani, K T Kalogeras, D Pectasides, G Fountzilas, H P Kalofonos, Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab Pharmacogenomics Journal. ,vol. 12, pp. 468- 475 ,(2012) , 10.1038/TPJ.2011.37
A Abajo, J Rodriguez, N Bitarte, R Zarate, V Boni, M Ponz, A Chopitea, E Bandres, J Garcia-Foncillas, Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients. British Journal of Cancer. ,vol. 103, pp. 1529- 1535 ,(2010) , 10.1038/SJ.BJC.6605908
Vincenzo Formica, Raffaele Palmirotta, Girolamo Del Monte, Annalisa Savonarola, Giorgia Ludovici, Maria Laura De Marchis, Italia Grenga, Michele Schirru, Fiorella Guadagni, Mario Roselli, Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab. International Journal of Colorectal Disease. ,vol. 26, pp. 143- 151 ,(2011) , 10.1007/S00384-010-1108-1
Heinz-Josef Lenz, Gene polymorphisms in vegf and vegf receptor 2 as markers for cancer therapy ,(2008)
Apostolos Papachristos, Theodora Katsila, Eirini Panoilia, Effrosyni Mendrinou, Anne John, Bassam R. Ali, Charalambos P. Kalofonos, George Patrinos, Gregory Sivolapenko, Can VEGFA and ICAM1 polymorphisms predict response to bevacizumab Journal of Clinical Oncology. ,vol. 36, pp. 2521- 2521 ,(2018) , 10.1200/JCO.2018.36.15_SUPPL.2521